30.05
price up icon1.21%   0.36
after-market 시간 외 거래: 30.10 0.05 +0.17%
loading

Edgewise Therapeutics Inc (EWTX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
19.47%
55.98
46.86 42.61 45.96 40.43
Operating Income/Loss
19.47%
-55.98
-46.86 -42.61 -45.96 -40.43
Income/Loss From Continuing Operations Before Tax
23.50%
-50.22
-40.67 -36.12 -40.80 -34.13
Income/Loss From Continuing Operations After Tax
23.51%
-50.23
-40.67 -36.12 -40.80 -34.13
Net Income/Loss
23.48%
-50.22
-40.67 -36.12 -40.80 -34.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.02%
1.0383
105.49 104.94 95.13 93.81
Diluted Average Shares
99.02%
1.0383
105.49 104.94 95.13 93.81
Basic Earnings Per Share
23.08%
-0.48
-0.39 -0.34 -0.43 -0.36
Diluted Earnings Per Share
23.08%
-0.48
-0.39 -0.34 -0.43 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):